2 weeks Ago
Castle Biosciences ( NASDAQ: CSTL ) is scheduled to announce Q3 earnings results on Monday, November 4th, after market close. The consensus EPS Estimate is $0.01 and the consensus Revenue Estimate is $78.
99M (+28.4% Y/Y). Over the last 3 months, EPS estimates have seen 8 upward revisions and 0 downward.
Revenue estimates have seen 9 upward revisions and 0 downward. More on Castle Biosciences Castle Biosciences: Inflection Into Profitability Castle Biosciences, Inc. (CSTL) Q2 2024 Earnings Call Transcript Castle Biosciences Q2 2024 Earnings Preview Seeking Alpha’s Quant Rating on Castle Biosciences Historical earnings data for Castle Biosciences.
